Global scale Sartorius operates with a broad global footprint across more than 60 production and sales sites and a diverse workforce of over 14,000 employees from 110+ nations, signaling large-scale opportunities for cross-border instrument and consumables sales, regional service contracts, and multinational account management.

Bioprocess leadership With a broad bioprocess portfolio centered on single-use solutions for manufacturing biotech medicines, vaccines, and cell and gene therapies, there is a strong sales potential for automation, scale-up consumables, and turnkey manufacturing solutions as customers expand from discovery to production.

Innovation partner Sartorius positions itself as a partner that accelerates progress from drug discovery to manufacturing, offering opportunities to upsell integrated laboratory instruments, consumables, andQUALITY control solutions to pharma and academic research customers undergoing process optimization and digitalization.

Acquisition-friendly growth Regular portfolio expansion through complementary technology acquisitions creates opportunities to pitch integrated best-in-class solutions, co-developed products, or migration paths from legacy systems to Sartorius platforms for existing customers seeking modernization.

Financial scale With revenue in the higher end of the mid-market and a substantial funding base, Sartorius has the resources to invest in large-scale contracts, long-term service agreements, and bundled equipment-and-service deals that appeal to mid-to-large biopharma manufacturers and contract development and manufacturing organizations.